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Abstract
Adenocarcinoid of the appendix is an infrequent tumor with histologic features of both adeno-
carcinoma and carcinoid tumor. Although its malignant potential remains unclear, adenocarcinoids
seem to be biologically more aggressive than conventional carcinoids. The aim of this study was to
analyze long-term results of surgical treatment for appendiceal adenocarcinoid. A retrospective
review (1991–2003) identified seven patients (median age 72, range 27–81 years) treated for
appendiceal adenocarcinoid. The clinical data of these patients were reviewed. Follow-up was
complete for all patients (median 60 months, range 24–108 months). Most cases presented with
associated acute appendicitis (71%). First intention surgery consisted of appendectomy (m = 6)
and right hemicolectomy (m = 1). In three patients, additional surgical procedures were performed
(right colectomy). Indications for colectomy were tumor size (three cases) associated with
appendectomy margin invasion in one case. One patient with lymph node and peritoneal
involvement experienced recurrence 9 months after hemicolectomy and died of the disease at 2
years. One patient subsequently died of colon carcinoma 6 years after adenocarcinoid treatment.
Five patients were alive without disease at the time of the last follow-up. Synchronous or meta-
chronous colon carcinomas developed in three patients (43%). Our results suggest that appen-
dectomy alone could be used for appendiceal adenocarcinoid provided that the tumor (1) is less
than 1 cm; (2) does not extend beyond the appendix adventitia; (3) has less than 2 mitoses/10
high power fields; and (4) has surgical margins that are tumor free. Otherwise, carcinologic right
colectomy seems to be indicated. The risk for developing colorectal adenocarcinoma seems to be
extremely high in patients treated for appendiceal adenocarcinoid and warrants close follow-up
with colonoscopic screening.
Adenocarcinoid, alternatively named goblet cell carci-noid, of the appendix is an uncommon tumor. It was
first described as a specific entity in 1969 by Gagne et al.1
and eventually coined ‘‘adenocarcinoid’’ by Warkel et al.2
Although adenocarcinoids share histologic features with
adenocarcinoma and carcinoid tumor, it is biologically
distinct from both. The aggressiveness of the adenocarci-
noid is still unclear.3 but is probably more aggressive than
the carcinoid and less so than colorectal adenocarci-
noma.4–6 In particular, adenocarcinoid has a propensity for
ovarian metastasis and principally peritoneal carcinoma-
tosis.3,7
Debates continue as to whether the appendiceal ade-
nocarcinoid should be treated by appendectomy alone, as
for most carcinoids, or if right hemicolectomy is indicated
as for the appendiceal adenocarcinoma.7 This study was
undertaken to review the long-term results of surgical
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treatment of appendiceal adenocarcinoids and evaluate the
role of appendectomy alone in selected cases.
MATERIALS AND METHODS
A retrospective review identified seven patients treated
for appendiceal adenocarcinoid in a single institution be-
tween January 1991 and December 2003. An experienced
pathologist reviewed the histologic diagnoses. Three of
these cases were previously reported in an article on sur-
gical treatment of appendiceal tumors.8 Preoperative,
postoperative, and long-term follow-up information was
obtained from patients charts, family physicians, and
questionnaires. Follow-up was complete for all patients.
RESULTS
Study Population and Pathologic Diagnosis
Appendiceal adenocarcinoid were diagnosed in seven
patients. The median follow-up was 60 months (range 24–
87 months). The median age was 72 years (range 27–81
years). The male/female ratio was 6:1. Most patients pre-
sented with clinical symptoms of acute appendicitis, and
tumors were not suspected in any of them preoperatively.
Associated acute appendicitis was confirmed by pathology
examination in 71% of the resected specimen. Appendix
perforation was detected in two patients (29%) with acute
appendicitis.
Adenocarcinoid localization along the appendix was the
apex (m = 4), middle third (m= 1), and proximal third
(m = 2). The median tumor size was 1.1 cm (range 0.7–3.0
cm). In four cases (57%) the tumor was more than 1 cm in
diameter. One case presented peritoneal invasion and a
positive lymph node in the mesoappendix. Tumor char-
acteristics are summarized in Table 1.
Surgical Treatment
First intention surgery was open appendectomy in six
cases. In one patient the diagnosis of an appendiceal tumor
was suspected peroperatively, and a right hemicolectomy
was performed. This patient had a 3 cm adenocarcinoid in
the absence of associated acute appendicitis. All patients
with an adenocarcinoid >1 cm underwent subsequent
carcinologic right colectomy, except the one who had a
first intention colectomy. Among these three patients, one
had invaded the appendectomy margin, and one had ap-
pendiceal peritoneal surface invasion and lymph node
invasion in the mesoappendix.
Long-term Follow-up
The median follow-up was 60 months (range 24–87
months). The overall 5-year actuarial survival was 83%.
The three patients who underwent appendectomy for a < 1
cm tumor were all alive without evidence of disease at a
median follow-up of 84 months (range 36–87 months).
Two patients among those who presented with a tumor > 1
cm underwent right colectomy and are alive without re-
currence 3 and 5 years after surgery, respectively. One
patient with a 2.5 cm adenocarcinoid presented with
peritoneal carcinomatosist 9 months after right hemi-
colectomy and died of the disease at 2 years. The last pa-
tient developed subsequent metachronous colorectal
adenocarcinoma and died 6 years after adenocarcinoid
resection.
Associated Cancer
Three patients (43%) developed an associated colorectal
cancer during follow-up for their adenocarcinoid tumor.
Synchronous colon cancer (adenocarcinoma) was discov-
ered in one patient (14%), and metachronous colon car-
cinomas were encountered in two patients (29%). Their
Table 1.
Adenocarcinoid histologic features, treatment, and follow-up.
Tumor size
(cm)
Appendix
wall invasion
Lymph node
invasion
Mitosis/10
high power fields
Appendectomy
margins invaded Surgical treatment Follow-up status
0.7 Adventitia No 0 No Appendectomy NED at 87 months
0.7 Adventitia No 0 No Appendectomy NED at 84 months
0.9 Adventitia No 0 No Appendectomy NED at 36 months
1.2 Mesoappendix No 0 Yes Appendectomy and hemicolectomy NED at 35 months
1.5 Adventitia No 1 No Appendectomy and hemicolectomy NED at 60 months
2.5 Peritoneum Yes 3 No Appendectomyand hemicolectomy DOD at 24 months
3.0 Mesoappendix No 0 No Hemicolectomy DFD at 75 months
NED: no evidence of disease; DFD: died free of disease; DOD: died of disease
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median age was 72 years (range 60–81 years). In none of
these patients were there known predisposing factors or
pathologic conditions for colorectal carcinoma.
DISCUSSION
We analyzed the long-term results of surgical treatment
for appendiceal adenocarcinoids. Our data indicate that
appendectomy alone is curative for patients presenting with
small adenocarcinoids (< 1 cm) not expanding beyond the
appendix and with a low mitosis rate. Otherwise, extended
resection (i.e., right colectomy) should be proposed.
Adenocarcinoids and goblet cell carcinoids share histo-
logic features of both conventional carcinoids and colonic
type adenocarcinomas.9 Its most frequent site of occurrence
is the appendix. Although 40 years after its first description.1
the histologic characteristics of this tumor have been well
described.4 its biologic behavior is still not clearly defined.10
Its malignant potential has been reported as between that of
a carcinoid and a colonic adenocarcinoma.4–6 Adenocarci-
noid have a propensity for ovarian metastasis and perito-
neal carcinomatosis.3,7 Recently, the natural history of
peritoneal carcinomatosis from appendiceal adenocarci-
noid has been shown to be similar to that of adenocarci-
noma.3 Clinically, adenocarcinoid is a relatively indolent
neoplasm not associated with carcinoid syndrome.2 which
is usually discovered in association with acute appendicitis,
as was the case in 70% of patients in our series.
No consensus has been determined for appendiceal ad-
enocarcinoid treatment in the world literature because of
the low prevalence of this pathology, with experience
based only on small series.7 There is still debates as to
whether they should be treated by appendectomy alone, as
for most carcinoids, or it right hemicolectomy is indicated
as for appendiceal adenocarcinoma.7,11 Moreover, no
definitive staging system has been validated for appendi-
ceal adenocarcinoid, and the value of the TNM staging
system has never been tested. The malignant potential of
appendiceal adenocarcinoids is evaluated similar to ap-
pendiceal carcinoids: tumor size and mitosis rate. The re-
sults of published series on surgical treatment of
adenocarcinoid.2,6,10,12–22 are summarized in Table 2. In
accordance with these data, our results support the idea
that appendectomy alone is associated with good results in
patients with a small (< 1 cm) adenocarcinoid not ex-
panding beyond the appendix and a low mitosis rate. By
contrast, adenocarcinoids > 1 cm in size, with a mitosis
Table 2.
Published series reporting clinical outcomes of appendiceal adenocarcinoids.
Appendectomy
Extended
resection
Study Cases Total Failurea Total Failurea Recommendations
Subbuswamy et al.12 12 8 0 3 1 AP alone if no cecal invasion
Wolf and Ahmed13 2 1 0 0 0 Treated as appendiceal adenocarcinoma
Haqqani and williams14 6 5 1 0 0 AP alone if no invasion, ER if cecal invasion
Warkel et al.2 39 14 2 13 0 ER if spread beyond appendix,
‡ 2 mitoses/10 HPF
Chen and Qizilbash15 5 3 0 2 0 AP alone if no cecal invasion
Olsson and Ljunberg16 4 3 0 1 1 ER if spread beyond appendix,
‡ 2 mitoses/10 HPF
Edmonds et al.17 10 3 0 3 1 ER for all adenocarcinoids
Watson and Alguacil18 6 0 0 2 0 No recommendation
Bak and Asschemfeldt19 20 8 0 6 0 ER if spread beyond appendix,
‡ 2 mitoses/10 HPF
Park et al.20 10 7 1 3 1 ER for all adenocarcinoids
Rutledge and Alexander et al.6 3 1 0 2 0 ER for all adenocarcinoids
Butler et al.21 9 3 0 1 0 AP alone if no cecal invasion,
oophorectomy for females
Li et al.22 11 3 0 5 0 ER if MiB1 > 3%, TNM N1 or M1
Aizawa et al.10 2 1 0 1 0 ER if spread beyond appendix,
‡ 2 mitoses/10 HPF
This series 7 3 0 4 1 See discussion
Total 146 63 4 (6.3%) 46 5 (11%)
AP: appendectomy; ER: extended resection; HPF: high power field; MiB1: proliferation index.
aFailure is defined as adenocarcinoid recurrence or metastatic disease
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count of > 2/10 HPF, and/or spreading beyond appendi-
ceal adventitia are probably better treated with an ex-
tended resection (i.e., right colectomy in accordance with
Varisco et al..7 Although experience with adjuvant treat-
ment of adenocarcinoid is sparse, two recent reports have
shown encouraging results for peritoneal carcinomatosis
treatment: cytoreduction and intraperitoneal chemother-
apy.3 or for metastatic cases Folfox chemotherapy.23
Patients treated for appendiceal tumors, including car-
cinoids, have an increased risk of a second cancer.8,24 The
high risk for developing synchronous or metachronous
colorectal adenocarcinoma in patients with adenocarcinoid
is intriguing. In our series, three of seven (43%) patients
treated for appendiceal adenocarcinoid developed colo-
rectal adenocarcinoma. None of these patients had a
known pathologic condition predisposing to colorectal
carcinoma. Thus colonoscopic examination plays an
important role in patients with incidentally discovered
appendiceal adenocarcinoid; this diagnostic modality
seems to be particularly indicated in patients in their sixth
to eighth decades. Moreover, patient follow-up should
include an endoscopic surveillance program, coloscopy
every 5 years, after appendiceal adenocarcinoid treatment.
CONCLUSIONS
According to our results and the literature, it appears that
appendectomy alone may be curative for appendix ade-
nocarcinoids provided the tumor is < 1 cm, does not ex-
tend beyond the appendix adventitia, has less than 2
mitoses/10 HPF, and the surgical margins are free of tumor.
For all other patients a right colectomy is indicated. Be-
cause of a high risk of synchronous and metachronous
colorectal adenocarcinoma in patients with adenocarci-
noids, we recommend postoperative and follow-up
screening for all patients with coloscopy.
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